Promore Pharma AB (publ) announced the composition of the Nomination Committee for the Annual General Meeting 2023, which will be held on 23 May 2023. Accordingly, the following committee members have been appointed: Marianne Dicander Alexandersson, Chairman of the Board; David Sundin, representing Corespring New Technology AB (former Midroc New Technology); Candice Jung, representing PharmaResearch Co. Ltd; and Jari Pulkkinen, representing a co-registered group of shareholders, with an ownership equivalent to 8.1% of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.35 SEK | +2.08% | -9.82% | -36.22% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.22% | 14.04M | |
+7.80% | 115B | |
+12.68% | 107B | |
-13.33% | 22.31B | |
-3.99% | 21.6B | |
-6.37% | 18.23B | |
-39.93% | 17.62B | |
+6.57% | 14.26B | |
+32.57% | 12.37B | |
-28.58% | 8.28B |
- Stock Market
- Equities
- PMDS Stock
- News PMD Device Solutions AB
- Promore Pharma AB Announces Composition of Nomination Committee